Clinical Trial

Outcomes of Treatment Using the ERMI Shoulder Flexionater ®

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated August 7, 2025 (before its estimated October 25, 2025 completion). Its status may not reflect the trial's current state.
Summary
Study 1 - Adhesive Capsulitis Study - 110 patients The purpose of this study is to compare treatment of patients with symptoms of adhesive capsulitis, primary and secondary, between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device. Study 2 - Postoperative Shoulder Stiffness Study - 90 patients The purpose of this study is to compare treatment of patients with post-operative stiffness indicative of secondary adhesive capsulitis between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device. Study 3 - Stiffness after MUA Study - enroll all eligible patients (goal of at least 15) The purpose of this study is to compare treatment of patients who have undergone manipulation under anesthesia or lysis of adhesions between three groups: I) Physical Therapy alone; II) ERMI Shoulder Flexionater® alone; III) PT + Device.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2022-05-17; most recent amendment 2025-08-04.
Trial Details
NCT Number NCT05384093
Lead Sponsor Foundation for Orthopaedic Research and Education
Collaborators: Ermi LLC
Conditions Adhesive Capsulitis of Shoulder
Enrollment 210 participants
Start Date 2019-06-25
Primary Completion 2025-10-25 (estimated)
Study Completion 2026-06-25 (estimated)
Updated on ClinicalTrials.gov 2025-08-07